Abstract 4682: Sunitinib (SU) in advanced NSCLC: Correlation of circulating biomarkers with clinical outcome

Charles S. Harmon; Sam E. DePrimo; Mark Socinski; Giorgio Scagliotti; Rafael Rosell; Ramaswamy Govindan; Ray D. Page; John Hainsworth; Julie R. Brahmer; Normand Blais; Silvia Novello; Lesley Tye; Sindy Kim; James A. Williams; Richard Chao

doi:10.1158/1538-7445.AM10-4682

Abstract 4682: Sunitinib (SU) in advanced NSCLC: Correlation of circulating biomarkers with clinical outcome

Charles S. Harmon
, Sam E. DePrimo
, Mark Socinski
, Giorgio Scagliotti
, Rafael Rosell
, Ramaswamy Govindan
, Ray D. Page
, John Hainsworth
, Julie R. Brahmer
, Normand Blais
, Silvia Novello
, Lesley Tye
, Sindy Kim
, James A. Williams
, Richard Chao

Pfizer
University of North Carolina at Chapel Hill
University of Turin
5Catalan Institute of Oncology, Barcelona, Spain
Washington University in St. Louis
7Center for Cancer and Blood Disorders, Fort Worth, TX
Sarah Cannon Research Institute
Johns Hopkins University
10Hopital Notre Dame du CHUM, Montreal, Quebec, Canada.

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Cancer Research
Volume	70
DOIs	https://doi.org/10.1158/1538-7445.AM10-4682
State	Published - Apr 15 2010
Externally published	Yes

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1158/1538-7445.AM10-4682License: Unspecified

Cite this

Harmon, C. S., DePrimo, S. E., Socinski, M., Scagliotti, G., Rosell, R., Govindan, R., Page, R. D., Hainsworth, J., Brahmer, J. R., Blais, N., Novello, S., Tye, L., Kim, S., Williams, J. A., & Chao, R. (2010). Abstract 4682: Sunitinib (SU) in advanced NSCLC: Correlation of circulating biomarkers with clinical outcome. Cancer Research, 70. https://doi.org/10.1158/1538-7445.AM10-4682

@article{cb030506c6d84b358b1633e5976d8247,

title = "Abstract 4682: Sunitinib (SU) in advanced NSCLC: Correlation of circulating biomarkers with clinical outcome",

author = "Harmon, \{Charles S.\} and DePrimo, \{Sam E.\} and Mark Socinski and Giorgio Scagliotti and Rafael Rosell and Ramaswamy Govindan and Page, \{Ray D.\} and John Hainsworth and Brahmer, \{Julie R.\} and Normand Blais and Silvia Novello and Lesley Tye and Sindy Kim and Williams, \{James A.\} and Richard Chao",

note = "Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC Introduction SU is an oral multitargeted inhibitor of VEGFRs, PDGFRs, KIT, FLT3, CSF-1R and RET. Antitumor activity and safety of SU in NSCLC were reported in phase II trials. We investigated potential biomarkers of clinical outcome with SU in NSCLC.",

year = "2010",

month = apr,

day = "15",

doi = "10.1158/1538-7445.AM10-4682",

language = "American English",

volume = "70",

journal = "Cancer Research",

issn = "1538-7445",

publisher = "American Association for Cancer Research",

}

TY - JOUR

T1 - Abstract 4682: Sunitinib (SU) in advanced NSCLC: Correlation of circulating biomarkers with clinical outcome

AU - Harmon, Charles S.

AU - DePrimo, Sam E.

AU - Socinski, Mark

AU - Scagliotti, Giorgio

AU - Rosell, Rafael

AU - Govindan, Ramaswamy

AU - Page, Ray D.

AU - Hainsworth, John

AU - Brahmer, Julie R.

AU - Blais, Normand

AU - Novello, Silvia

AU - Tye, Lesley

AU - Kim, Sindy

AU - Williams, James A.

AU - Chao, Richard

N1 - Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC Introduction SU is an oral multitargeted inhibitor of VEGFRs, PDGFRs, KIT, FLT3, CSF-1R and RET. Antitumor activity and safety of SU in NSCLC were reported in phase II trials. We investigated potential biomarkers of clinical outcome with SU in NSCLC.

PY - 2010/4/15

Y1 - 2010/4/15

UR - https://cancerres.aacrjournals.org/content/70/8_Supplement/4682

U2 - 10.1158/1538-7445.AM10-4682

DO - 10.1158/1538-7445.AM10-4682

M3 - Article

SN - 1538-7445

VL - 70

JO - Cancer Research

JF - Cancer Research

ER -

Abstract 4682: Sunitinib (SU) in advanced NSCLC: Correlation of circulating biomarkers with clinical outcome

Disciplines

Access to Document

Other files and links

Cite this